H. B. Fuller Q3 Estimates Show Modest Growth Amid Recent Price Decline

H. B. Fuller is projected to report a 15.9% rise in EPS and a 5.4% increase in revenue for the upcoming quarter, according to consensus estimates compiled by GN markets/earnings (en-US).
H. B. Fuller (FUL) is expected to deliver a 15.9% year-over-year increase in earnings per share to $1.46 for the current quarter. Concurrently, total revenues are forecast to climb 5.4% to $940.38 million. These figures represent the current consensus view ahead of the official earnings release.
Despite these positive growth metrics, the stock has experienced a recent downturn. Over the past month, FUL shares have fallen 14.8%, significantly underperforming the Zacks S&P 500 composite, which saw a 1.3% decline. This divergence highlights a disconnect between fundamental expectations and short-term market sentiment.
Segment Revenue Projections Indicate Steady Demand
The Hygiene, Health, and Consumable Adhesives segment is the largest contributor to the revenue forecast. Analysts project net revenue for this division to reach $405.74 million, marking a 5.1% increase from the same period last year. This growth rate slightly outpaces the overall company revenue expansion.
The Engineering Adhesives segment is also expected to grow, with consensus estimates placing net revenue at $279.86 million. This represents a 2.8% year-over-year improvement. While slower than the hygiene division, this segment remains a critical pillar of the company's diversified industrial portfolio.
Operating Profitability Expected to Rise Across Divisions
Profitability metrics suggest improved operational efficiency across key business units. Adjusted EBITDA for the Engineering Adhesives segment is estimated at $65.17 million, up from $63.43 million in the prior year quarter. This indicates a modest margin expansion in the industrial adhesives market.
In the Building Adhesive Solutions division, adjusted EBITDA is projected to hit $44.08 million, compared to $41.47 million reported in the same quarter last year. The Hygiene, Health, and Consumable Adhesives segment shows the strongest profit growth, with adjusted EBITDA expected to reach $71.86 million from a year-ago base of $65.32 million.
Recent Estimate Revisions Reflect Cautious Outlook
The consensus EPS estimate has been revised downward by 1.9% over the last 30 days. This adjustment signals that analysts have collectively moderated their expectations following initial projections. Such revisions often serve as a leading indicator for short-term price performance, as they reflect updated views on the company's near-term trajectory.
H. B. Fuller currently holds a Zacks Rank #3 (Hold), suggesting its performance will likely align with the broader market. The combination of solid projected growth and recent negative revisions creates a mixed outlook for investors monitoring the upcoming earnings report.






